- 全部删除
 
您的购物车当前为空
Daclizumab (Zenapax)为人源化单抗,能特异性地抑制IL-2R-HA的α亚单位。Daclizumab (Zenapax)能通过与CD25的特异性结合而抑制IL-2和IL-2R-HA的结合。Daclizumab (Zenapax)研究多发性硬化症 。

为众多的药物研发团队赋能,
让新药发现更简单!
Daclizumab (Zenapax)为人源化单抗,能特异性地抑制IL-2R-HA的α亚单位。Daclizumab (Zenapax)能通过与CD25的特异性结合而抑制IL-2和IL-2R-HA的结合。Daclizumab (Zenapax)研究多发性硬化症 。
| 规格 | 价格 | 库存 | 数量 | 
|---|---|---|---|
| 1 mg | ¥ 997  | In stock | |
| 5 mg | ¥ 2,890  | In stock | |
| 10 mg | ¥ 4,990  | In stock | |
| 25 mg | ¥ 7,790  | In stock | |
| 50 mg | ¥ 10,500  | In stock | |
| 100 mg | ¥ 14,200  | In stock | 
Daclizumab 相关产品
| 产品描述 | Daclizumab (Zenapax) is a humanized monoclonal antibody that specifically inhibits the alpha subunit of IL-2R-HA. Daclizumab (Zenapax) can inhibit the binding of IL-2 and IL-2R-HA through specific binding to CD25. Daclizumab (Zenapax) studies multiple sclerosis.  | 
| 别名 | 达昔单抗, Zenapax, Ro 24-7375 | 
| 分子量 | 144.12 kDa | 
| CAS No. | 152923-56-3 | 
| 颜色 | Transparent | 
| 物理性状 | Liquid | 
| 存储 | store at low temperature | -20°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | 
评论内容